financetom
Business
financetom
/
Business
/
Joby Aviation's Begins Expansion of California Electric Air Taxi Production Facility
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Joby Aviation's Begins Expansion of California Electric Air Taxi Production Facility
Apr 30, 2024 1:26 AM

04:13 AM EDT, 04/30/2024 (MT Newswires) -- Joby Aviation ( JOBY ) said Monday it has begun a plan to expand its electric aircraft factory in Marina, California.

The company said the expansion will more than double its manufacturing footprint at Marina Municipal Airport and is expected to begin operations next year, increasing production capacity to a rate of 25 aircraft a year.

The state of California is partly funding the expansion with a $9.8 million grant.

During the groundbreaking ceremony, the electric air taxi company also showed visitors its second production prototype.

Shares of the company were up more than 1% in Monday's after-hours activity.

Price: 5.25, Change: +0.06, Percent Change: +1.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Samsung fourth-quarter profit growth slows as chip issues weigh
Samsung fourth-quarter profit growth slows as chip issues weigh
Jan 30, 2025
SEOUL (Reuters) -Samsung Electronics ( SSNLF ) reported fourth-quarter profit that rose 130% from a low base, confirming it had missed earlier estimates due to slowing memory chip demand and extra costs as it works towards providing high-end chips to Nvidia ( NVDA ). Samsung said that in the first quarter of 2025, overall earnings improvement may be limited due...
Biotech firm Maze Therapeutics raises $140 million in US IPO
Biotech firm Maze Therapeutics raises $140 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech listing this year. Maze priced the offering at $16 per share, within its indicated range of $15 to $17. ...
Weight-loss drug developer Metsera raises $275 million in US IPO
Weight-loss drug developer Metsera raises $275 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company said on Thursday. ...
Lawmakers urge Trump to consider new curbs on Nvidia chips used by China's DeepSeek
Lawmakers urge Trump to consider new curbs on Nvidia chips used by China's DeepSeek
Jan 30, 2025
* Two US lawmakers alleged DeepSeek has relied on Nvidia ( NVDA ) chips * Lawmakers wrote letter to US national security adviser Michael Waltz * Congressional offices have reportedly been warned not to use DeepSeek (Adds Axios reporting warning for congressional offices against using DeepSeek in paragraphs 6, 7) WASHINGTON, Jan 30 (Reuters) - Two members of U.S. Congress...
Copyright 2023-2026 - www.financetom.com All Rights Reserved